PHLPP2
Basic information
Region (hg38): 16:71637835-71724701
Previous symbols: [ "PHLPPL" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PHLPP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 75 | 81 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 77 | 8 | 1 |
Variants in PHLPP2
This is a list of pathogenic ClinVar variants found in the PHLPP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-71640475-T-A | not specified | Uncertain significance (Oct 29, 2021) | ||
16-71640944-G-A | not specified | Uncertain significance (Jun 18, 2021) | ||
16-71648900-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
16-71648993-T-A | not specified | Uncertain significance (Jul 25, 2023) | ||
16-71649008-T-C | not specified | Likely benign (Aug 10, 2021) | ||
16-71649009-G-T | not specified | Uncertain significance (Jul 11, 2023) | ||
16-71649014-A-G | not specified | Uncertain significance (Jan 17, 2024) | ||
16-71649182-T-C | not specified | Uncertain significance (Apr 27, 2024) | ||
16-71649315-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
16-71649341-C-A | not specified | Uncertain significance (Jun 13, 2023) | ||
16-71649390-C-T | not specified | Uncertain significance (May 09, 2023) | ||
16-71649414-C-G | not specified | Uncertain significance (Dec 27, 2023) | ||
16-71649426-C-T | not specified | Uncertain significance (Dec 03, 2021) | ||
16-71649436-C-A | not specified | Uncertain significance (Jan 23, 2023) | ||
16-71649446-G-C | Likely benign (Mar 01, 2018) | |||
16-71649488-G-T | not specified | Uncertain significance (Nov 17, 2022) | ||
16-71649495-T-G | not specified | Uncertain significance (Feb 04, 2022) | ||
16-71649515-C-T | not specified | Uncertain significance (Jul 12, 2022) | ||
16-71649527-G-A | not specified | Uncertain significance (Jul 20, 2021) | ||
16-71649597-C-A | not specified | Uncertain significance (Aug 22, 2023) | ||
16-71649644-C-T | not specified | Uncertain significance (Apr 26, 2023) | ||
16-71649690-T-C | not specified | Uncertain significance (Feb 28, 2024) | ||
16-71649702-C-T | not specified | Uncertain significance (Dec 21, 2023) | ||
16-71649803-T-C | not specified | Uncertain significance (Oct 12, 2022) | ||
16-71649856-G-A | Benign (Mar 01, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PHLPP2 | protein_coding | protein_coding | ENST00000568954 | 18 | 86867 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000121 | 1.00 | 125689 | 0 | 59 | 125748 | 0.000235 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.631 | 765 | 717 | 1.07 | 0.0000386 | 8641 |
Missense in Polyphen | 270 | 286.29 | 0.9431 | 3515 | ||
Synonymous | -1.65 | 324 | 288 | 1.12 | 0.0000156 | 2688 |
Loss of Function | 4.48 | 21 | 57.7 | 0.364 | 0.00000353 | 654 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000362 | 0.000300 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000489 | 0.000489 |
Finnish | 0.000417 | 0.000416 |
European (Non-Finnish) | 0.000238 | 0.000237 |
Middle Eastern | 0.000489 | 0.000489 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Protein phosphatase involved in regulation of Akt and PKC signaling. Mediates dephosphorylation in the C-terminal domain hydrophobic motif of members of the AGC Ser/Thr protein kinase family; specifically acts on 'Ser-473' of AKT1, 'Ser-660' of PRKCB isoform beta-II and 'Ser-657' of PRKCA. Akt regulates the balance between cell survival and apoptosis through a cascade that primarily alters the function of transcription factors that regulate pro- and antiapoptotic genes. Dephosphorylation of 'Ser- 473' of Akt triggers apoptosis and decreases cell proliferation. Also controls the phosphorylation of AKT3. Dephosphorylates STK4 on 'Thr-387' leading to STK4 activation and apoptosis (PubMed:20513427). Dephosphorylates RPS6KB1 and is involved in regulation of cap-dependent translation (PubMed:21986499). Inhibits cancer cell proliferation and may act as a tumor suppressor. Dephosphorylation of PRKCA and PRKCB leads to their destabilization and degradation. Dephosphorylates RAF1 inhibiting its kinase activity (PubMed:24530606). {ECO:0000269|PubMed:17386267, ECO:0000269|PubMed:18162466, ECO:0000269|PubMed:19079341, ECO:0000269|PubMed:20513427, ECO:0000269|PubMed:21986499, ECO:0000269|PubMed:24530606}.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway;Signal Transduction;PIP3 activates AKT signaling;Negative regulation of the PI3K/AKT network;Intracellular signaling by second messengers
(Consensus)
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- loftool
- 0.658
- rvis_EVS
- -1.23
- rvis_percentile_EVS
- 5.56
Haploinsufficiency Scores
- pHI
- 0.519
- hipred
- N
- hipred_score
- 0.495
- ghis
- 0.583
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.433
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Phlpp2
- Phenotype
- growth/size/body region phenotype; immune system phenotype; digestive/alimentary phenotype;
Gene ontology
- Biological process
- protein dephosphorylation;hippocampus development
- Cellular component
- photoreceptor inner segment;nucleus;cytoplasm;cytosol;photoreceptor outer segment membrane
- Molecular function
- protein serine/threonine phosphatase activity;protein binding;metal ion binding